This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator.
Specific Aims : To evaluate the safety and tolerability of intramuscular administrations of the HIV CTL MEP vaccine formulated with RC539-SE with and without GM-CSF
Showing the most recent 10 out of 515 publications